Royce & Associates’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.03M Hold
71,475
0.04% 492
2025
Q4
$5.73M Sell
71,475
-629,767
-90% -$42.3M 0.06% 442
2025
Q3
$34.2M Sell
701,242
-569,815
-45% -$35.3M 0.34% 74
2025
Q2
$94.8M Buy
1,271,057
+109,761
+9% +$7.27M 0.97% 3
2025
Q1
$73.8M Buy
1,161,296
+8,028
+0.7% +$546K 0.8% 8
2024
Q4
$90M Sell
1,153,268
-57,278
-5% -$4.6M 0.84% 7
2024
Q3
$97.3M Buy
1,210,546
+30,868
+3% +$2.49M 0.88% 6
2024
Q2
$97.6M Sell
1,179,678
-86,936
-7% -$7.65M 0.91% 5
2024
Q1
$108M Buy
1,266,614
+300,259
+31% +$23.6M 0.96% 4
2023
Q4
$82.6M Buy
966,355
+18,805
+2% +$1.63M 0.76% 14
2023
Q3
$84.9M Buy
947,550
+41,258
+5% +$3.68M 0.86% 9
2023
Q2
$77.2M Buy
906,292
+62,538
+7% +$5.29M 0.75% 13
2023
Q1
$69.8M Buy
843,754
+18,292
+2% +$1.48M 0.7% 17
2022
Q4
$64.9M Sell
825,462
-49,346
-6% -$3.97M 0.68% 20
2022
Q3
$64.8M Buy
874,808
+33,223
+4% +$2.39M 0.73% 16
2022
Q2
$54.9M Buy
841,585
+84,341
+11% +$4.99M 0.56% 33
2022
Q1
$47.9M Buy
757,244
+49,136
+7% +$2.67M 0.41% 47
2021
Q4
$37.6M Sell
708,108
-276,250
-28% -$16.8M 0.28% 80
2021
Q3
$69.5M Buy
984,358
+382,812
+64% +$24.2M 0.52% 29
2021
Q2
$40.1M Buy
601,546
+132,961
+28% +$9.41M 0.28% 81
2021
Q1
$52M Sell
468,585
-130,171
-22% -$16.1M 0.35% 55
2020
Q4
$71.1M Buy
598,756
+15,148
+3% +$1.63M 0.59% 19
2020
Q3
$50.9M Buy
583,608
+90,415
+18% +$7.9M 0.55% 28
2020
Q2
$44.2M Buy
493,193
+116,588
+31% +$11.8M 0.49% 40
2020
Q1
$37.5M Buy
376,605
+346,436
+1,148% +$37.6M 0.51% 39
2019
Q4
$3.47M Buy
+30,169
New +$3.65M 0.03% 579
2018
Q3
Sell
-19,300
Closed -$1.73M 1194
2018
Q2
$1.73M Sell
19,300
-700
-4% -$59.1K 0.01% 859
2018
Q1
$1.46M Buy
20,000
+19,792
+9,515% +$1.36M 0.01% 917
2017
Q4
$12K Sell
208
-41
-16% -$2.16K ﹤0.01% 1148
2017
Q3
$11K Buy
+249
New +$10.3K ﹤0.01% 1149
2013
Q4
Sell
-224,100
Closed -$8.94M 1453
2013
Q3
$8.94M Sell
224,100
-103,900
-32% -$4.36M 0.03% 697
2013
Q2
$13.6M Buy
+328,000
New +$13.3M 0.04% 509

Other funds holding HAE